1. The symptom response of rabeprazole sodium treatment does not rule out the existence of gastric cancer or esophageal cancer. Therefore, the possibility of cancer should be ruled out before starting to use this product for treatment. Although no obvious drug-related safety problems were found in the age and gender matching control study between patients with mild and moderate liver injury and normal people, doctors suggested that patients with severe liver injury should pay special attention when using this product for the first time.

2. When taking this product, blood tests and blood biochemical tests (such as liver enzyme tests) should be carried out regularly. If any abnormality is found, the drug should be stopped and treated in time.

3. Use with caution in patients with liver function injury.

Medication for pregnant and lactating women

Pregnant and lactating women are prohibited.

Children's medication

The safety for children has not been determined (inexperienced).

Medication for elderly patients

This drug is mainly metabolized by the liver. Generally, the elderly have low function and will have side effects. If there are serious side effects, the medication should be suspended.